Heart Disease Clinical Trials in New York

Showing 401-420 of 585 trials

Reversing Ticagrelor's Effects With Fresh Platelets

NCT02201394

Acute coronary syndrome (ACS) patients treated with antiplatelet drugs who require coronary artery bypass grafting (CABG) surgery have to wait 5-7 days for the effects of the drugs to wean off. This treatment-devoid period leaves the patient vulnerable, therefore any means to shorten this period could be useful. The present study aims to investigate the possibility of reversing the antiplatelet effects of ticagrelor with the help of fresh donor platelets. Fresh platelets will be added to blood samples of treated patients in varying concentrations at specific timepoints to determine the time and amount of fresh platelets needed to normalize platelet reactivity in the treated samples.

Coronary Artery Disease

Icahn School of Medicine at Mount Sinai20 participantsStarted Jul 2014

New York, New York, United States

COMPLETEDPhase 3< 1 mile

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

NCT00116428

This trial compares the safety and effectiveness of catheter ablation for PAF with antiarrhythmic drug therapy. The investigational catheter being studied is the NAVISTAR® THERMOCOOL® irrigated-tip catheter. At the time of this study, the NAVISTAR® THERMOCOOL® catheter was FDA-approved for commercial distribution in the U.S. for treating patients with Type I atrial flutter and drug refractory monomorphic ventricular tachycardia post myocardial infarction. The catheter was approved for use in Europe for endocardial ablation for treating cardiac arrhythmias.

Heart DiseasesArrhythmiaAtrial Fibrillation

Biosense Webster, Inc.167 participantsStarted Oct 2004

Greenbrae, California, United States • Orlando, Florida, United States • Maywood, Illinois, United States +14 more locations

Reversing Ticagrelor's Effects With Fresh Platelets

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Heart Disease Trials in Other Cities

Relationship Between Diet, Lifestyle, and the Severity of Coronary Artery Disease

An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery

A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions

Safety Study of Pyridostigmine in Heart Failure

Geriatric Out of Hospital Randomized Meal Trial in Heart Failure

An Observational Study of Cholesterol in Coronary Arteries

Naltrexone/Bupropion Cardiovascular Outcomes Study

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

"ALOFT - Aliskiren Observation of Heart Failure Treatment": Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure

Telehealth Management in HF Disparity Patients

Mobile Health Monitoring Solution for Heart Failure Patients

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event

Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.

A Trial of Behavioral Economic Interventions to Reduce Cardiovascular Disease (CVD) Risk

Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure

Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients

Other Conditions in New York